NCT01976468进行中（未招募）不适用
Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 100
- 试验地点
- 2
- 主要终点
- SCC metastasis detection
研究概览
简要总结
The investigators hypothesize that a low number of SCC in OTR will metastasize.
详细描述
In a large international multicenter prospective observational study a total number of 1000 OTR (organ transplant recipients) with a histologically proven cutaneous SCC (squamous cell carcinoma) will be included in 10 centers and followed during 2 years to establish the cumulative incidence of metastases in OTR with cutaneous SCC.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
SCC metastasis detection
时间窗: two years
次要结局
未报告次要终点
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Metastases of cutaneous squamous cell carcinoma in organ transplant recipients - The *SCOPE-ITSCC metastases study*10040900Skin cancersquamous cell carcinomaNL-OMON39568eids Universitair Medisch Centrum300
招募中
2 期
Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell CarcinomaCutaneous Squamous Cell Carcinoma of the Head and NeckHead and Neck CancerNCT05025813Queensland Health27
进行中（未招募）
不适用
Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic TherapyEsophagus Squamous Cell CarcinomaSquamous Cell Carcinoma of the Head and NeckAnal Canal Squamous Cell CarcinomaMetastatic CancerCancerNCT03712566University Health Network, Toronto39
进行中（未招募）
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-DEEO Pharma A/S480
进行中（未招募）
1 期
Risk of Skin Cancer on Skin Areas Treated with Ingenol Mebutate Gel, 0.015% and Imiquimod Cream, 5%EUCTR2012-003112-31-FREO Pharma A/S480